Streptococcus pneumoniae Serotype Distribution and Pneumococcal Conjugate Vaccine Serotype Coverage among Pediatric Patients in East and Southeast Asia, 2000-2014: a Pooled Data Analysis

Vaccines
Stanley S Tai

Abstract

Pneumococcal infection is one of the leading causes of death worldwide, especially in children of developing and underdeveloped countries. Capsular polysaccharide-based vaccines are available for the prevention of this disease. A 7-valent pneumococcal conjugate vaccine (PCV7) was licensed in 2000 for use in children less than two years of age. Subsequently, to broaden the protection, 10-valent (PCV10) and 13-valent (PCV13) vaccines were licensed in 2009 and 2010, respectively. All of these conjugate vaccines elicit an immune response that only provides protection against the infection of S. pneumoniae serotypes included in the formulation. Profiles of S. pneumoniae serotype distribution and serotype coverage for both PCV7 and PCV13 have been reported in some Asian countries/territories. But the published results cannot provide conclusive information due to the difference in studied population and geographic areas. The goals of this review are to obtain an accurate estimate of serotype coverage for PCV7, PCV10, and PCV13 and examine the change in the S. pneumoniae serotype distribution after PCV7 use among pediatric patients in East and Southeast Asia through the analysis of pooled data that were published in the English literat...Continue Reading

References

Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W P HausdorffG R Siber
Feb 15, 2001·The New England Journal of Medicine·J EskolaUNKNOWN Finnish Otitis Media Study Group
May 2, 2003·The New England Journal of Medicine·Cynthia G WhitneyUNKNOWN Active Bacterial Core Surveillance of the Emerging Infections Program Network
Aug 25, 2004·Emerging Infectious Diseases·Pak-Leung HoYu-Lung Lau
Oct 9, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Faryal GhaffarGeorge H McCracken
Feb 8, 2006·The Pediatric Infectious Disease Journal·Sunisa LevineSonja J Olsen
Apr 13, 2006·JAMA : the Journal of the American Medical Association·Katherine A PoehlingWilliam Schaffner
Mar 19, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S YuY Yang
May 24, 2008·Vaccine·Chia-Yin ChongTee Wen-Sim Nancy
Oct 4, 2008·Journal of Clinical Microbiology·Muneki HotomiUNKNOWN Advanced Treatment for Otitis Media Study Group (ATOMS)
Feb 24, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Henry C BaggettSusan A Maloney
Apr 28, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Y-C HsiehP-R Hsueh
Apr 28, 2009·Vaccine·L C Bravo, UNKNOWN Asian Strategic Alliance for Pneumococcal Disease Prevention (ASAP) Working Group
May 8, 2009·Pediatrics International : Official Journal of the Japan Pediatric Society·Misao TakanoTatsuo Yamamoto
Jun 23, 2009·Epidemiology and Infection·N ChibaUNKNOWN IPD Surveillance Study Group
Sep 15, 2009·Lancet·Katherine L O'BrienUNKNOWN Hib and Pneumococcal Global Burden of Disease Study Team
Feb 2, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lian XueYonghong Yang
Apr 8, 2010·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sungkyoung LeeSongmee Bae
Nov 26, 2010·Diagnostic Microbiology and Infectious Disease·Byung Wook EunHoan Jong Lee
Dec 17, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Fuminori SakaiTakashi Takahashi
Dec 18, 2010·Expert Review of Vaccines·E David G McIntosh, Ralf R Reinert
Feb 19, 2011·Journal of Medical Microbiology·J M C JefferiesS C Clarke

❮ Previous
Next ❯

Citations

Jan 31, 2017·Vaccines·Marco Cavallari, Gennaro De Libero
Mar 8, 2018·Journal of Extracellular Vesicles·Priyanka SharmaTheresa L Whiteside
Feb 21, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Malihe TalebiMohammad Reza Pourshafie
Jul 1, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Maryam Alizadeh ChamkhalehMaziar Moradi-Lakeh

❮ Previous
Next ❯

Software Mentioned

Office Excel

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.